Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2017-02-10
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Limb Health and Socket Pressure in Response to Powered Ankle Protheses
NCT05112679
Comparing Active and Passive Ankle-foot Prostheses
NCT01684501
Comparing New Prothesis PROPRIO-FOOT® Versus Usual Prothesis Tasks Tibial Amputees
NCT02501408
1C70 Feasibility Study
NCT05628064
Comparative Effectiveness of Microprocessor Controlled and Carbon Fiber Prosthetic Feet in Transtibial Amputees
NCT02864693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
emPOWER Ankle (powered prosthesis)
The subject's own passive prosthesis will be used as a baseline and crossed over after the emPOWER has been worn 3-4 months. Then the passive foot will be crossed back to the emPOWER for a final series of tests.
emPOWER Ankle
The device is 510k cleared and is intended to replace a missing foot and ankle. The emPOWER Ankle is to be used exclusively for fittings of lower-extremity amputations as prescribed by a healthcare professional.
Subject's own passive prosthesis
Devices will vary. Data gathered will form a baseline.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
emPOWER Ankle
The device is 510k cleared and is intended to replace a missing foot and ankle. The emPOWER Ankle is to be used exclusively for fittings of lower-extremity amputations as prescribed by a healthcare professional.
Subject's own passive prosthesis
Devices will vary. Data gathered will form a baseline.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 55 years or older
* Subjects with transtibial amputations of either leg at least 1 year prior
* Suction or elevated vacuum suspension and Socket Comfort Score of at least 6
* Sock fluctuation of ≤ 8 ply per day
* K-level rating of 3 or 4 based on the Amputee Mobility Predictor Assessment Tool
* Ability to walk at a walking speed of \> 0.75 meters per second
* Unilateral amputees (up to 7 bilateral amputees can be included, 1 per site in addition to the unilateral amputees who will be analyzed as a separate sub group)
* Foot size: 25-30 cm
* Ability to complete a continuous 6-Minute Walk Test
* Ability to provide written, informed consent
* Ability to complete study visits and study documents
* Ability to manage the complexity of a powered device including charging and changing batteries as needed
* Ability to read and understand English
Exclusion Criteria
* Less than 55 years of age
* Weight \<150 lbs. or \> 287 lbs.
* Transfemoral amputees
* Active sores or ulceration on subject's residual limb
* Sore on contralateral foot.
* Cuff-link socket suspension
* Socket Comfort Score less than 6
* Sock fluctuation of \> 8 per day
* K level of 1 or 2
* Amputation clearance \< 8.625"
* History of stroke or TIA that impairs current walking
* Recent history of excessive falling defined as more than 2 falls requiring medical assistance in the prior year
* Medications potentially affecting balance
* Recent hospitalization (within past 3 months)
* Cognitive deficiency that would impact ability to charge and change batteries as needed
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BionX Medical Technologies, Inc.
INDUSTRY
Otto Bock Healthcare Products GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Melton, M.D.
Role: PRINCIPAL_INVESTIGATOR
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UTHealth, Department of Orthopedic Surgery
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P16-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.